Eli Lilly, one of the leading manufacturers of insulin, announced they are slashing the price of their most commonly prescribed insulin, by 70 percent. The company is capping the out-of-pocket price for insured patients at $35.

source

LEAVE A REPLY

Please enter your comment!
Please enter your name here